achondroplasia

Summary
Synonym
  • Achondroplastic physique
  • Chondrodystrophia
  • osteosclerosis congenita
Definition
An osteochondrodysplasia that is characterized by short stature caused by rhizomelic shortening of the limbs, characteristic facies with frontal bossing and midface hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, genu varum, and trident hand and that has_material_basis_in heterozygous mutation in the fibroblast growth factor receptor-3 gene (FGFR3) on chromosome 4p16.3. Achondroplasia results in dwarfism due to the abnormal ossification of cartilage in the long bone.
Super Class
osteochondrodysplasia
External Links
Disease Ontology
DOID:4480
Mondo Disease Ontology
MeSH
UMLS
NCI Thesaurus
OMIM
GARD
MGI genotype (from TogoID)
WikiPathways (from TogoID)
Related Genes
Displaying entries 121 - 130 of 138 in total
Gene ID Gene Symbol Description Source
55331 ACER3 alkaline ceramidase 3
55343 SLC35C1 solute carrier family 35 member C1
55512 SMPD3 sphingomyelin phosphodiesterase 3
55790 CSGALNACT1 chondroitin sulfate N-acetylgalactosaminyltransferase 1
55858 TMEM165 transmembrane protein 165
57104 PNPLA2 patatin like phospholipase domain containing 2
64116 SLC39A8 solute carrier family 39 member 8
64131 XYLT1 xylosyltransferase 1
79158 GNPTAB N-acetylglucosamine-1-phosphate transferase subunits alpha and beta
79947 DHDDS dehydrodolichyl diphosphate synthase subunit
Related Glycoprotein
Displaying entry 111 - 111 of 111 in total
UniProt ID Protein Name Source
Q9Y6Z7 Collectin-10

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024